About Stealth BioTherapeutics
Stealth BioTherapeutics is a company based in Newton (United States) founded in 2007 was acquired by Morningside in August 2022.. Stealth BioTherapeutics has raised $100 million across 2 funding rounds from investors including CMBC Capital, Morningside and Atlantis Investment. The company has 31 employees as of December 31, 2020. Stealth BioTherapeutics offers products and services including Elamipretide. Stealth BioTherapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Mereo BioPharma and Amicus Therapeutics, among others.
- Headquarter Newton, United States
- Employees 31 as on 31 Dec, 2020
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Stealth Biotherapeutics Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$100 M (USD)
in 2 rounds
-
Latest Funding Round
$20 M (USD), Post-IPO
Apr 13, 2020
-
Investors
CMBC Capital
& 7 more
-
Employee Count
31
as on Dec 31, 2020
-
Acquired by
Morningside
(Aug 01, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stealth BioTherapeutics
Stealth BioTherapeutics offers a comprehensive portfolio of products and services, including Elamipretide. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational therapy to restore mitochondrial function in diseases.
Unlock access to complete
Funding Insights of Stealth BioTherapeutics
Stealth BioTherapeutics has successfully raised a total of $100M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $20.0M
-
First Round
First Round
(18 Jan 2018)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Post-IPO - Stealth BioTherapeutics | Valuation |
investors |
|
| Jan, 2018 | Amount | Private Equity Round - Stealth BioTherapeutics | Valuation | Nan Fung Life Sciences |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Stealth BioTherapeutics
Stealth BioTherapeutics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include CMBC Capital, Morningside and Atlantis Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Founded Year | Domain | Location | |
|
VC firm funding companies in China and the US
|
Founded Year | Domain | Location | |
|
Private equity investments are focused on life science companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Stealth BioTherapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Stealth BioTherapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stealth Biotherapeutics Comparisons
Competitors of Stealth BioTherapeutics
Stealth BioTherapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Mereo BioPharma and Amicus Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapies for rare and orphan diseases
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat rare genetic diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Stealth Biotherapeutics
Frequently Asked Questions about Stealth BioTherapeutics
When was Stealth BioTherapeutics founded?
Stealth BioTherapeutics was founded in 2007 and raised its 1st funding round 11 years after it was founded.
Where is Stealth BioTherapeutics located?
Stealth BioTherapeutics is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
Who is the current CEO of Stealth BioTherapeutics?
Reenie McCarthy is the current CEO of Stealth BioTherapeutics.
Is Stealth BioTherapeutics a funded company?
Stealth BioTherapeutics is a funded company, having raised a total of $100M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $100M, raised on Jan 18, 2018.
How many employees does Stealth BioTherapeutics have?
As of Dec 31, 2020, the latest employee count at Stealth BioTherapeutics is 31.
What does Stealth BioTherapeutics do?
Founded in 2007 and based in Newton, United States, the biotechnology company is engaged in developing peptide therapies for rare mitochondrial diseases and associated dysfunctions. Mitochondrial Carrier Technology is employed to deliver active candidates to mitochondria. The lead product, Elamipretide, functions as a tetrapeptide that stabilizes cardiolipin, thereby supporting electron transfer and inhibiting apoptosis. Applications are targeted at skeletal, ocular, and cardiorenal conditions stemming from mitochondrial impairment.
Who are the top competitors of Stealth BioTherapeutics?
Stealth BioTherapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Stealth BioTherapeutics offer?
Stealth BioTherapeutics offers Elamipretide.
Who are Stealth BioTherapeutics's investors?
Stealth BioTherapeutics has 8 investors. Key investors include CMBC Capital, Morningside, Atlantis Investment, BioVeda China Fund, and Kingdon Capital Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.